Skip to main content

Advertisement

Table 1 Baseline demographic, clinical and angiographic data of patients with and without complete ST-resolution

From: Association of admission testosterone level with ST-segment resolution in male patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

Variables Complete ST-resolution N = 35 (72.9%) Incomplete ST-resolution N = 13 (27.1%) P value
Mean age (years ± SD) 54.9 ± 12.01 57.15 ± 13.05 0.58
Hypertension, n (%) 7 (20%) 2 (15.4%) 0.71
Diabetes Mellitus, n (%) 4 (11.4%) 2 (15.4%) 0.65
Hyperlipidemia, n (%) 4 (11.4%) 0 (0%) 0.56
Smoking, n (%) 15 (42.9%) 6 (46.2%) 0.83
Ischemic time ≤6 h 21 (60%) 4 (30.8%) 0.07
  >6 h 14 (40%) 9 (69.2%)
Medication use on admission Aspirin, n (%) 3 (8.57%) 2 (15.38%) 0.6
Beta-blockers, n (%) 1 (2.86%) 1 (7.7%) 0.47
ACE-inhibitors, n (%) 4 (11.4%) 1 (7.7%) 0.7
Statins, n (%) 1 (2.86%) 0 (0%) 0.53
Mean Syntax score ± SD 20.48 ± 9.04 21.92 ± 9.92 0.63
Mean Systolic blood pressure ± SD, mmHg 132.20 ± 26.03 129.66 ± 24.59 0.77
Mean Diastolic blood pressure ± SD, mmHg 83.48 ± 16.22 78.16 ± 13.94 0.32
LVEF, (%) ± SD 41.61 ± 10.27 43.84 ± 4.63 0.45
Anterior MI, n (%) 19 (54.3%) 7 (53.8%) 0.97
Pre-procedural TIMI flow, n (%)    0.31
 0–1 31 (88.6%) 10 (76.9%)
 2–3 4 (11.4%) 3 (23.1%)
  1. ACE-inhibitor Angiotensin converting enzyme inhibitor, Syntax score Synergy between PCI with Taxus and Cardiac Surgery, LVEF Left ventricular ejection fraction, MI Myocardial Infarction, TIMI Thrombolysis in Myocardial Infarction